Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald L Kimpel

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
The American Journal of Medicine|May 6, 2008
Catching a breakAngela Tubb, Evan Liokis, Bennett Alford, et al.
Clinical Chemistry|October 30, 2015
Persistence of Infliximab in Circulation for 7 Years?Sarah M Kelting, Donald L Kimpel, David E Bruns
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 19, 2018
Collaboration Between Rheumatology and Oncology in Immune Checkpoint Inhibitor TherapyDonald L Kimpel, Janet E Lewis, Elizabeth Gaughan, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 14, 2011
Contrast-enhanced magnetic resonance imaging positively impacts the management of some patients with rheumatoid arthritis or suspected RAMichael G Fox, Tausha Stephens, Wael N Jarjour, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|March 26, 2014
Systemic lupus erythematosus presenting as Stevens-Johnson syndrome/toxic epidermal necrolysisMary Grace Baker, Nicole D Cresce, Mariam Ameri, et al.
Expert Review of Clinical Immunology|May 19, 2010
Clinical implication of autoantibodies in patients with systemic rheumatic diseasesMinoru Satoh, Edward Kl Chan, Eric S Sobel, et al.
The Journal of Clinical Investigation|July 19, 2013
Isocitrate ameliorates anemia by suppressing the erythroid iron restriction responseChanté L Richardson, Lorrie L Delehanty, Grant C Bullock, et al.
Frontiers in Immunology|November 5, 2024
Activating <i>STAT3</i> mutations in CD8+ T-cells correlate to serological positivity in rheumatoid arthritisKatharine B Moosic, Thomas L Olson, Mark Freijat, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The American Journal of Medicine|May 6, 2008
Catching a breakAngela Tubb, Evan Liokis, Bennett Alford, et al.
Clinical Chemistry|October 30, 2015
Persistence of Infliximab in Circulation for 7 Years?Sarah M Kelting, Donald L Kimpel, David E Bruns
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 19, 2018
Collaboration Between Rheumatology and Oncology in Immune Checkpoint Inhibitor TherapyDonald L Kimpel, Janet E Lewis, Elizabeth Gaughan, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 14, 2011
Contrast-enhanced magnetic resonance imaging positively impacts the management of some patients with rheumatoid arthritis or suspected RAMichael G Fox, Tausha Stephens, Wael N Jarjour, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|March 26, 2014
Systemic lupus erythematosus presenting as Stevens-Johnson syndrome/toxic epidermal necrolysisMary Grace Baker, Nicole D Cresce, Mariam Ameri, et al.
Expert Review of Clinical Immunology|May 19, 2010
Clinical implication of autoantibodies in patients with systemic rheumatic diseasesMinoru Satoh, Edward Kl Chan, Eric S Sobel, et al.
The Journal of Clinical Investigation|July 19, 2013
Isocitrate ameliorates anemia by suppressing the erythroid iron restriction responseChanté L Richardson, Lorrie L Delehanty, Grant C Bullock, et al.
Frontiers in Immunology|November 5, 2024
Activating <i>STAT3</i> mutations in CD8+ T-cells correlate to serological positivity in rheumatoid arthritisKatharine B Moosic, Thomas L Olson, Mark Freijat, et al.
Pageof 1